MedTrace Logo

Alport Syndrome Treatments and Outcomes Registry

NCT00481130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 655

Last updated 2025-11-25

No results posted yet for this study

Summary

ASTOR's primary purpose is to enroll families and patients with a history of Alport syndrome in a central registry. The information we gather will be used as a basis for studies designed to test potential treatments for Alport syndrome. ASTOR also aims to provide patients, families and physicians with the most up-to-date information about Alport syndrome.

Conditions

  • Alport Syndrome

Sponsors & Collaborators

Principal Investigators

  • Clifford Kashtan, MD · University of Minnesota, Department of Pediatrics

Eligibility

Min Age
0 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2025-11-17
Completion
2025-11-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00481130 on ClinicalTrials.gov